Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.

Industry and academic leaders will describe how small immune cell subsets shape the human immune response.

LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.

The newly minted Baylor College of Medicine faculty member is working to crack the mystery of triple negative breast cancer.

Daohong Zhou and Aileen Frost explore how they target the proteolysis mechanism and fight cancer using proteolysis targeting chimera (PROTAC) technology.

Discover how researchers are using flow cytometry to delve into the inner workings of the immune life cycle!

Molly Shoichet and Bridget Wagner discuss strategies for using phenotypic screening to identify novel agents against diseases such as cancer and diabetes.

The results add to mounting evidence of microbes’ roles in tumor growth and point to the possibility of impeding malignancies by inhibiting bacteria.